Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Caplin Point Laboratories Limited
Press Release Mar 28 2024
Business
Mar 28 2024
3 min read

Press Release Mar 28 2024

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 28, 2024, titled "Caplin Steriles Limited, our Subsidiary, gets USFDA approval for Ketorolac tromethamine Ophthalmic Solution 0.5%".

View Attachment